Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ABP Biosciences
United States
- Ownership
- Private
- Development stage
- Other
01
Overview
ABP Biosciences provides advanced fluorescent labeling and detection technologies for cell biology, molecular biology, and immunology research, enabling sensitive imaging, tracking, and analysis; not a clinical-stage company or therapeutic developer
- Therapeutic areas
- Other
- Modalities
- Small moleculePeptidesProteinsAntibodyNucleic Acid
- Industry
- Non-Drug Biotech
02
Partnerships
Hoelzel Biotech (distribution partner)Sapphire Bioscience (distribution partner)
Beyond the preview
Go deeper on ABP Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ABP Biosciences.